Skip to Content

Join the 'Liver Cancer' group to help and get support from people like you.

Liver Cancer News

Bristol-Myers Squibb’s Opdivo (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Posted 26 Sep 2017 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE) September 22, 2017 --Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection for intravenous use for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. Approval for this indication has been granted under accelerated ...

Stivarga Approved for Liver Cancer

Posted 28 Apr 2017 by Drugs.com

THURSDAY, April 27, 2017 – U.S. Food and Drug Administration approval of the anti-cancer drug Stivarga (regorafenib) has been expanded to include liver cancer, the agency said Thursday in a news release. Stivarga, among a class of drugs called kinase inhibitors, is designed to block enzymes that foster cancer growth. It's the first drug approved to treat liver cancer in nearly a decade, the FDA ...

FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma

Posted 28 Apr 2017 by Drugs.com

April 27, 2017 – The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib. This is the first FDA-approved treatment for a liver cancer in almost a decade. “Limited treatment options are available for patients with l ...

Ask a Question